Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens
ObjectiveTuberculosis diagnosis requires rapid, simple and highly sensitive methods. Clustered regularly interspaced short palindromic repeats (CRISPRs) and associated protein (Cas) systems are increasingly being used for clinical diagnostic applications, due to their high flexibility, sensitivity a...
Main Authors: | Weicong Ren, You Zhou, Haoran Li, Yuanyuan Shang, Xuxia Zhang, Jinfeng Yuan, Shanshan Li, Chuanyou Li, Yu Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1117085/full |
Similar Items
-
CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
by: Jing-Wen Ai, et al.
Published: (2019-01-01) -
High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01) -
Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01) -
More Than a Decade of GeneXpert<sup>®</sup> <i>Mycobacterium tuberculosis</i>/Rifampicin (Ultra) Testing in South Africa: Laboratory Insights from Twenty-Three Million Tests
by: Manuel Pedro da Silva, et al.
Published: (2023-10-01) -
Breast tuberculosis: A forgotten diagnosis
by: S. Oucharqui, et al.
Published: (2021-01-01)